Moreover, studies investigating gene therapy targeting klotho protein in the management of neurodegenerative disorders and diabetes mellitus have been conducted [34–36], although there is a clear need for multiple large-scale therapeutic clinical trials for a better understanding of the role of klotho in the management of CKD. Here, KL is linked to diabetes mellitus.